期刊文献+

银杏内酯B注射液对Beagle犬的长期毒性研究 被引量:7

Long Term Toxicity of Ginkgolide B Injection on Beagle Dogs
原文传递
导出
摘要 目的:研究银杏内酯B注射液的长期毒性,为临床试验提供安全性依据。方法:将Beagle犬分为空白对照及银杏内酯B注射液高、中、低剂量(80、20、5mg·kg-1)组,每组6只,♀♂各半,每天静脉滴注给药,每周连续给药6d,共90d,实验时检查各剂量组犬的体重、食量、体温、心电图、血液学、血液生化学、眼科、骨髓、尿常规、病理组织学等,并进行恢复性观察。结果:给药期间,银杏内酯B注射液高剂量组有1只犬出现1次呕吐症状,高、中剂量组犬凝血时间显著延长;恢复期高剂量组有1只犬出现尿蛋白强阳性;各指标显示未见与药物有关的显著毒性反应。结论:银杏内酯B注射液对Beagle犬的无毒反应剂量为20mg·kg-1。 OBJECTIVE: To evaluate the long- term toxicity of Ginkgolide B injection on Beagle dogs, and to provide safety evidences for clinical experiment .METHODS: A total of 24 Beagle dogs were equally assigned to receive placebo (control group, n = 6) or Ginkgolide B injection at high, medium, and low doses (80, 20, and 5 mg ·kg^ -1) by iv gtt for 6 consecutive days per week for up to 90 days.There were 6 Beagle dogs (male: female = 1 : 1) in each group. All the laboratory indicators were monitored and the recovery of the Beagle dogs was observed. RESULTS: During medication, vomiting was noted in one dog in high dose group, and the clotting time in high and medium dose groups was prolonged obviously. During the recovery stage, one dog in high dose group was strong positive in urinary protein test. No significant drugassociated toxic reactions were noted judging from Beagle dogs' body weight, appetite, temperature, ECG, hematology, blood biochemical analysis, ophthalmology test, marrow test, urine routine test, histopathologic examination etc. CONCLUSION: The non - toxic dose of Ginkgolide B injection for Beagle dogs was 20 mg ·kg^ -1 .
机构地区 解放军总医院
出处 《中国药房》 CAS CSCD 北大核心 2008年第30期2338-2341,共4页 China Pharmacy
关键词 银杏内酯B注射液 BEAGLE犬 长期毒性 Ginkgolide B injection Beagle dog Long-term toxicity
  • 相关文献

参考文献3

二级参考文献17

  • 1刘宗潮,简少文,李华忠,欧景才,李端.抗EB病毒口服液对EB病毒转化力的抑制作用[J].肿瘤防治杂志,2004,11(8):790-792. 被引量:6
  • 2李仪奎.中药新药的长期毒性试验(一).中药新药药理与临床,1994,5(2):50-50.
  • 3Zettler ME, Prociuk MA, Austria JA, et al. OxLDL stimulates cell proliferation through a general induction of cell cycle proteins [J]. Am J Physiol Heart Circ Physiol,2003,284:644 - 653.
  • 4Brocheriou I, Stengel D, Mattsson-Huhen L, et al.Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis [J]. Circulation, 2000, 102:2569 -2555.
  • 5Silva AR, de Assis EF, Caiado LF, et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein [J]. J Immunol, 2002,168:4112 - 4120.
  • 6Chai YC, Binion DG, Chisolm GF. Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation [J]. Am J Physiol Heart Circ Physiol, 2000,279 : 1830 - 1838.
  • 7Marathe GK, Zimmerman GA, Prescott SM, et al.Activation of vascular cells by PAF-like lipids in oxidized LDL [J]. Vascul Pharmacol, 2002,38:193-200.
  • 8De Castellarnau C, Sanchez-Quesada JL, Benitez S, et al. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells [J]. Arterioscler Thromb Vasc Biol, 2000,20:2281 - 2287.
  • 9Chien MW, Chien CS, Hsiao LD, et al. OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cells [J]. J Lipid Res, 2003,44 : 1667 - 1675.
  • 10Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology [J].Physiol Rev, 2000,80 : 1669 - 1699.

共引文献14

同被引文献106

引证文献7

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部